Following the success of the Patient Partnership Index 2021, OVID Health is proud to release our Insights Paper which brings together the key lessons and advice from this year’s top partnerships, as well as the expert insight of senior leaders in pharma and patient advocacy, and our judging panel, from our virtual event in July, ‘What’s next for patient advocacy?”
Our paper, ‘How to Build Future-Proof Patient Partnerships’, explores the practical advice for creating long-lasting and impactful communications and advocacy partnerships that build on the current trends in patient-centricity.
The Patient Partnership Index is a first-of-its-kind initiative from OVID Health and PharmaTimes, launched in May 2020, designed to set the benchmark for what makes a successful partnership between pharma and patient groups. Entries are awarded GOLD, SILVER or FINALIST standard by the expert judging panel for the Index, which this year included: Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation; Elliot Dunster, Executive Director, Corporate Affairs and Devolved Nations, ABPI; Selina McKee, Editor-in-Chief of PharmaTimes; and OVID Health’s MD Jenny Ousbey.
To help share best practice and raise the standard for patients, we’ve made our Insights Paper free and easy to access online. You can read and download the Index Insights Paper 2021 here.
If you have any questions, comments, or think OVID Health can help with your next patient advocacy project, contact us at firstname.lastname@example.org to organise for your next discussion.